Xcout IntelAlamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Subscribe to see Alamar Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alamar Biosciences, Inc. at a glance
Alamar Biosciences, Inc. is a biotechnology company headquartered in Fremont, United States. It is publicly listed (ALMR) with a market capitalisation of $1.8B. Xcout tracks 17 named people at Alamar Biosciences, Inc., including Timothy O. White (President). Xcout recorded 45 job postings from Alamar Biosciences, Inc. in the last 90 days.
Alamar Biosciences, Inc. leadership
- Timothy O. WhitePresident
- Justin J. McAnearChief Financial Officer
- Xiao-Jun MaChief Technology Officer
- Stephen A. WilliamsChief Scientific Officer
- Yuling LuoCo-Founder, Chairman & CEO
- Shiping ChenCo-Founder, COO & Director
11 more named people on record for Alamar Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Alamar Biosciences, Inc.
Xcout recorded 45 job postings from Alamar Biosciences, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alamar Biosciences, Inc.'s hiring signals →
Recent Alamar Biosciences, Inc. news
- PartnershipAlamar Biosciences Partners with Leading Research ...
- IPOIPO registration (S-1)
- IPOAlamar Biosciences files for IPO amid opening life sciences ...
- IPOIPO registration (S-1)
7 corporate events on record, with sources — see the full timeline →
Hiring vs the trend
Based on 24 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 158 scale-up healthcare companies.
This describes a hiring pattern — how often Alamar Biosciences, Inc.’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Alamar Biosciences, Inc. competitors
A few of Alamar Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Biotrove, Inc., founded in 1997, is a developer and manufacturer of genomic analysis instruments, consumables, and technology platforms such as OpenArray. The company provides systems and services for molecular diagnostics, high-throughput screening, drug discovery, and life sciences research.
Esya Labs is a biotechnology and life sciences company with a corporate office located in Frisco, Texas. The company partners with entities like Alamar Biosciences to advance scientific research and diagnostics.
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Get Alamar Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Alamar Biosciences, Inc. in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 7 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access